Form 8-K - Current report:
SEC Accession No. 0001104659-25-034689
Filing Date
2025-04-14
Accepted
2025-04-14 16:15:32
Documents
13
Period of Report
2025-04-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512284d1_8k.htm   iXBRL 8-K 26851
  Complete submission text file 0001104659-25-034689.txt   200369

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20250411.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20250411_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20250411_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2512284d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 25836204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)